Cai, Y., Tang, G., Gao, X., Liu, J., Wang, L., Chen, M., Qi, L. (2026). Multi-omics profiling of residual cancer burden after neoadjuvant hormonal therapy guides subtype-directed treatment in high-risk and locally advanced prostate cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.245